Skip to main content

Abstract

This chapter is a very good occasion to clarify a concept which still today seems not to have been understood by a large part of the bariatric surgeons: biliopancreatic diversion (BPD) is not a particular operation, it is a mechanism of action, essentially consisting of delaying the meeting between food and biliopancreatic juices with the aim of reducing digestion, and thus intestinal absorption of the high-caloric nutrients which need to be digested for being absorbed. The mechanism itself does not necessarily provoke the obtainment of the goal, unless the time of contact between food and biliopancreatic secretions is insufficient to cause a complete digestion-absorption.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Biliopancreatic bypass for obesity: II. Initial experience in man. Br J Surg. 1979;66:618–9.

    Article  CAS  PubMed  Google Scholar 

  2. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A. Biliopancresatic diversion. World J Surg. 1998;22:936–46.

    Article  CAS  PubMed  Google Scholar 

  3. Bonalumi U, Cafiero F, Caponnetto A, Gianetta E, Reboa G, Civalleri D, Piccardo A, Berti Riboli E, Scopinaro N. Protein absorption studies in biliopancreatic bypass patients. Int J Obesity. 1981;5:543 (abstract).

    Google Scholar 

  4. Scopinaro N, Marinari GM, Camerini G, Pretolesi F, Papadia F, Murelli F, Marini P, Adami GF. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg. 2000;10:436–41.

    Article  CAS  PubMed  Google Scholar 

  5. Mortensen PB, Hove H, Clausen MR, Holtug K. Fermentation to short-chain fatty acids and lactate in human faecal batch cultures. Intra- and inter-individual variations versus variations caused by changes in fermented saccharides. Scand J Gastroenterol. 1991;26:1285–94.

    Article  CAS  PubMed  Google Scholar 

  6. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52:1098–103.

    Article  CAS  PubMed  Google Scholar 

  7. Vassallo C, Negri L, Della Valle A, Salvaneschi M, Vegezzi G, Griziotti A, Dono C, Mussi P, Bausardo MG, Pietrobono P. Biliopancreatic diversion with transitory gastroplasty preserving duodenal bulb: 3 years experience. Obes Surg. 1997;7:30–3.

    Article  CAS  PubMed  Google Scholar 

  8. Larrad-Jiménez A, Díaz-Guerra CS, de Cuadros Borrajo P, Lesmes IB, Esteban BM. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg. 2007;17(2):202–10.

    Article  PubMed  Google Scholar 

  9. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–82.

    Article  CAS  PubMed  Google Scholar 

  10. Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg. 1993;3:29–35.

    Article  PubMed  Google Scholar 

  11. Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–51.

    CAS  PubMed  Google Scholar 

  12. Griffen Jr WO. Gastric bypass for morbid obesity. Surg Clin North Am. 1979;59:1103–12.

    PubMed  Google Scholar 

  13. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4:353–7.

    Article  PubMed  Google Scholar 

  14. Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg. 1997;6:517–24.

    Article  Google Scholar 

  15. Brolin RE, Kenier HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg. 1992;215:387–95.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. MacLean LD, Rhode BM, Nohr CW. Long- or short-limb gastric bypass? J Gastrointest Surg. 2001;5:525–30.

    Article  CAS  PubMed  Google Scholar 

  17. Murr MM, Balsiger BM, Kennedy FP, Mail JL, Sarr MG. Malabsorptive procedures for severe obesity: comparison of pancreatobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg. 1999;3:607–12.

    Article  CAS  PubMed  Google Scholar 

  18. Scopinaro N, Marinari G, Camerini G, Papadia F. Biliopancreatic diversion for obesity: state of the art (2004 ASBS Consensus Conference). Surg Obes Relat Dis. 2005;1:317–28.

    Article  PubMed  Google Scholar 

  19. Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.

    Article  CAS  PubMed  Google Scholar 

  20. Sánchez-Pernaute A, Herrera MA, Pérez-Aguirre ME, Talavera P, Cabrerizo L, Matía P, Díez-Valladares L, Barabash A, Martín-Antona E, García-Botella A, Garcia-Almenta EM, Torres A. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three year follow-up. Obes Surg. 2010;20:1720–6.

    Article  PubMed  Google Scholar 

  21. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V. Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr. 1980;33:506–14.

    CAS  PubMed  Google Scholar 

  22. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM, Greve JW. A multicenter randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;216:236–43.

    Article  Google Scholar 

  23. Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg. 2002;12:241–4.

    Article  PubMed  Google Scholar 

  24. Scopinaro N. Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg. 2012;22:427–32.

    Article  PubMed  Google Scholar 

  25. Clare MW. Equal biliopancreatic and alimentary limbs: an analysis of 106 cases over 5 years. Obes Surg. 1993;3:289–95.

    Article  PubMed  Google Scholar 

  26. Scopinaro N, Gianetta E, Friedman D, Adami GF, Traverso E, Bachi V. Evolution of biliopancreatic bypass. Clin Nutr. 1986;5:137–46. First international symposium on obesity surgery, Genoa, Italy, October 1984.

    Article  Google Scholar 

  27. Marceau S, Biron S, Lagacé M, Hould FS, Potvin M, Bourque RA, Marceau P. Biliopancreatic diversion, with distal gastrectomy, 250 cm and 50 cm limbs: long-term results. Obes Surg. 1995;5:302–7.

    Article  PubMed  Google Scholar 

  28. Garcia JA, Martinez M, Aguilella V, Elia M, Royo P. Postoperative morbidity of biliopancreatic diversion depending on common limb length. Obes Surg. 2007;17:1306–11.

    Article  Google Scholar 

  29. Brolin RE. Long limb Roux en Y gastric bypass revisited. Surg Clin North Am. 2005;5:807–17.

    Article  Google Scholar 

  30. Nelson WK, Fatima J, Houghton SG, Thompson GB, Kendrick ML, Mai JL, Kennel KA, Sarr MG. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients. Surgery. 2006;140:517–22; discussion 522–3.

    Article  PubMed  Google Scholar 

  31. Scopinaro N. Physiology and semantics in obesity surgery. In: Deitel M, Cowan JR, editors. Update: surgery for the morbidly obese patients. Toronto: FD Communication Inc; 2000. p. 69–72.

    Google Scholar 

  32. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, D’Alessandro G, Parodi C, Weiss A, Andraghetti G, Catalano M, Cordera R. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30–35 kg/m2) and simple overweight (BMI 25–30 kg/m2): a prospective controlled study. Obes Surg. 2011;21:880–8.

    Article  PubMed  Google Scholar 

  33. Paiva D, Bernardes L, Suretti L. Laparoscopic biliopancreatic diversion: technique and initial results. Obes Surg. 2002;12(3):358–61.

    Article  PubMed  Google Scholar 

  34. Resa JJ, Solano J, Fatás JA, Blas JL, Monzón A, García A, Lagos J, Escartin J. Laparoscopic biliopancreatic diversion: technical aspects and results of our protocol. Obes Surg. 2004;14:329–33.

    Article  PubMed  Google Scholar 

  35. de Luis DA, Pacheco D, Izaola O, Romero A, Marcos JL, Pelaz J, Barrera A, Cabezas G, Terroba MC, Cuellar L, Anta A. Early clinical and surgical results of biliopancreatic diversion. Obes Surg. 2005;15:799–802.

    Article  PubMed  Google Scholar 

  36. de Luis DA, Pacheco D, Izaola O, Terroba MC, Cuellar L, Martin T. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab. 2008;53:234–9.

    Article  PubMed  Google Scholar 

  37. Vila M, Ruíz O, Belmonte M, Riesco M, Barceló A, Perez G, Moreiro J, Salinas R. Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obes Surg. 2009;19:299–306.

    Article  PubMed  Google Scholar 

  38. Murri M, García-Fuentes E, García-Almeida JM, Garrido-Sánchez L, Mayas MD, Bernal R, Tinahones FJ. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery. Obes Surg. 2010;20:363–8.

    Article  PubMed  Google Scholar 

  39. Garrido-Sanchez L, Murri M, Rivas-Becerra J, Ocaña-Wilhelmi L, Cohen RV, Garcia-Fuentes E, Tinahones FJ. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy. Surg Obes Relat Dis. 2012;2:145–50.

    Article  Google Scholar 

  40. García-Unzueta MT, Fernández-Santiago R, Domínguez-Díez A, Vazquez-Salví L, Fernández-Escalante JC, Amado JA. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up. Obes Surg. 2005;15:187–90.

    Article  PubMed  Google Scholar 

  41. Alagna S, Cossu ML, Gallo P, Tilocca PL, Pileri P, Alagna G, Maninchedda P, Sini AL, Pilo L, Rovasio PP, Noya G, Masala A. Biliopancreatic diversion: long-term effects on gonadal function in severely obese men. Surg Obes Relat Dis. 2006;2:82–6.

    Article  PubMed  Google Scholar 

  42. Moreiro J, Ruiz O, Perez G, Salinas R, Urgeles JR, Riesco M, García-Sanz M. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg. 2007;17:348–54.

    Article  CAS  PubMed  Google Scholar 

  43. Garcia-Fuentes E, Garrido-Sanchez L, Garcia-Almeida JM, Garcia-Arnes J, Gallego-Perales JL, Rivas-Marin J, Morcillo S, Cardona I, Soriguer F. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg. 2008;18:1424–9.

    Article  CAS  PubMed  Google Scholar 

  44. Hernández Hernández JR, López-Tomassetti Fernández E, Caballero Díaz Y, Molina Cabrillana J, Morales García D, Núñez Jorge V. Remission of female sexual dysfunction in morbidly obese female patients with the Scopinaro procedure. Surg Obes Relat Dis. 2013;9:987–90.

    Article  PubMed  Google Scholar 

  45. Quaranta L, Nascimbeni G, Semeraro F, Quaranta CA. Severe corneoconjunctival xerosis after biliopancreatic bypass for obesity (Scopinaro’s operation). Am J Ophthalmol. 1994;118:817–8.

    Article  CAS  PubMed  Google Scholar 

  46. Cossu ML, Fais E, Meloni GB, Profili S, Masala A, Alagna S, Rovasio PP, Spartà C, Pilo L, Tilocca PL, Noya G. Impact of age on long-term complications after biliopancreatic diversion. Obes Surg. 2004;14:1182–6.

    Article  PubMed  Google Scholar 

  47. Boldery R, Fielding G, Rafter T, Pascoe AL, Scalia GM. Nutritional deficiency of selenium secondary to weight loss (bariatric) surgery associated with life-threatening cardiomyopathy. Heart Lung Circ. 2007;16:123–6.

    Article  PubMed  Google Scholar 

  48. Ferrer Márquez M, Carvia Pousaillè C, Velasco Albendea J, Rico Morales Mdel M, Casado Martín M, Belda Lozano R, Ferrer Ayza M. Influence of bariatric surgery on the non-alcoholic liver steatosis. A histological evaluation. Cir Esp. 2009;86:94–100.

    Article  PubMed  Google Scholar 

  49. Geerts A, Darius T, Chapelle T, Roeyen G, Francque S, Libbrecht L, Nevens F, Pirenne J, Troisi R. The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery. Transplant Proc. 2010;42:4395–8.

    Article  CAS  PubMed  Google Scholar 

  50. Gracia-Solanas JA, Elia M, Aguilella V, Ramirez JM, Martínez J, Bielsa MA, Martínez M. Metabolic syndrome after bariatric surgery. Results depending on the technique performed. Obes Surg. 2011;21:179–85.

    Article  PubMed  Google Scholar 

  51. Frenken M, Cho EY. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB. Obes Facts. 2011;4 Suppl 1:13–7.

    Article  PubMed  Google Scholar 

  52. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  CAS  PubMed  Google Scholar 

  53. Doyle ME, Egan JM. Mechanisms of action of glucagone-like peptide 1 in the pancreas. Pharmacol Ther. 2007;113:546–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass. Diabetes. 1999;48:2270–6.

    Article  CAS  PubMed  Google Scholar 

  55. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R. Glucagon-like peptide 1 inhibits cell apoptosis and improve glucose responsiveness of freshly isolated human islets. Endocrinology. 2003;144:5149–58.

    Article  CAS  PubMed  Google Scholar 

  56. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  57. Scopinaro N, Papadia F, Camerini G, Marinari G, Civalleri D. A comparison of a personal series of biliopanreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg. 2008;18:1035–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicola Scopinaro FACS (Hon) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Scopinaro, N. (2015). Laparoscopic Biliopancreatic Diversion. In: Lucchese, M., Scopinaro, N. (eds) Minimally Invasive Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-15356-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15356-8_20

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15355-1

  • Online ISBN: 978-3-319-15356-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics